Dr. Jacqueline Lui, President of Eagle IP Group, spoke at the Breakout Session on Patent Commercialization at the 5th Annual US-China IP Conference in Shenzhen.

The conference was an annual event co-hosted by China Renmin University IP Academy, Berkeley Center for Law and Technology and Loyola Law School Los Angeles. The 5th US-China IP Conference, entitled “Intellectual Property and Economic Transformation”, brought together senior policymakers, judges, academics and international practitioners from China and the United States to discuss five important topics: (1) Recent Developments in Trade Secrets Law; (2) Privacy Protection under the Information Age; (3) Recent Developments in Entertainment Law; (4) Patent Commercialization; and (5) Brand Protection.

Our Past Events

Recommended Insights

China Top 10 Cases of 2020 – CNIPA Upholds Second Medical Use Patent from University of Bordeaux

24 May 2021
The development of China’s approach to patents, especially those in the pharmaceutical and biotech space, has been fascinating to watch. Those of us who have practiced in the area for a long time have been frustrated by the Chinese patent office’s overly strict rules regarding patentability (e.g., high data support standard and refusal to consider […]

China’s Newest Examination Guidelines: Novelty and Inventive Step for Compounds (Part II)

29 April 2021
This is Part II of a three-part series summarizing the Examination Guidelines that were released by the CNIPA on January 15, 2021, one year to the date of Phase 1 of the US and China Economic and Trade Agreement. That agreement included specific provisions where China "shall permit pharmaceutical patent applicants to rely on supplemental […]

What is the difference between an Invention Patent and a Utility Model Patent?

13 August 2021
There are two types of patent protection in China. Invention patents (similar to a US utility patent) have a term of 20 years from the date of filing and may be granted for both methods and products. Utility model patents (similar to a petty patent) may be granted in China for technical solutions that relate […]

No % homology? How to craft allowable claim scope around sequences to comply with China’s strict written description requirements

23 November 2018
Since 2010, the Patent Re-examination Board (PRB) has published the top 10 patent invalidation cases of the year in April of each year. The selection criteria are high social concern, significant impact on the related industry, or involve difficult legal issues and important examination criteria. Below is one of the top 10 cases that discusses […]
Top crossarrow-right